GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
- Details
- Category: GlaxoSmithKline

Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
- Details
- Category: AstraZeneca

FDA accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
- Details
- Category: Pfizer

Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)
- Details
- Category: Novo Nordisk

Bayer Pharmaceuticals accelerates innovations for patients
- Details
- Category: Bayer

Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
- Details
- Category: Novartis

CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
- Details
- Category: Business

In the last year, pharma has continued its rapid rate of innovation embracing the speed of pandemic R&D, but added to this are new social goals that aim to improve the wider world as well as bottom lines and therapeutic/device options.
More Pharma News ...
- Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
- BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
- Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
- AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge
- Pfizer invests $43 billion to battle cancer
- Pfizer's ZAVZPRET™ (zavegepant) migraine nasal spray receives FDA approval
- US FDA Advisory Committee votes to support effectiveness and safety of GSK's respiratory syncytial virus older adult vaccine candidate